CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Viral Disinfectant Efficacy Studies: Key Guiding Factors And Design Elements

  Achieving compliance and safety through Disinfectant Efficacy Studies (DES) is about adhering to regulations and committing to high standards of safety and quality of manufacturing operations.

• Assessing Viability And Real-Time Apoptosis/Necrosis

  Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.

• Peptide Mapping Of Adeno Associated Virus Capsid Proteins

  Peptide mapping helps reveal AAV capsid protein identity, sequence coverage, and potential modification patterns, giving gene therapy teams a clearer view of viral protein quality across workflows.

• Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation System

  Learn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.

• The Value Of Human Panel Testing Downstream Of Donor Screening In The Allogeneic Therapy Pipeline

  Allogeneic cell-based therapies require rigorous donor screening for adventitious viruses. qPCR-based assays enhance detection accuracy, sensitivity, and specificity, supplementing serological testing to ensure safer drug development and production.

• Laminar And Turbulent Mixing Techniques For LNP Formulations Scale Up

  Explore the critical factors in scaling up lipid nanoparticle (LNP) formulation, comparing the advantages and limitations of both laminar (microfluidic) and turbulent (tee and jet) mixing technologies.

• High-Throughput 90-Minute ELISA

  Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.

• Electroporation Enables The Efficient, Scalable Packaging Of CRISPR-Cas9 RNPs In Virus-Like Particles

  Discover how electroporation technology enables efficient, scalable production of CRISPR-Cas9 VLPs with high editing activity in both adherent and suspension HEK293 cells.

• Fast And Scalable Fc Quantitation In Supernatants

  In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.

• Enhancing AAV Production Performance And Economics

  Enzymatically produced dbDNA offers safer, faster, and more scalable AAV manufacturing by reducing costs, improving full capsid yields, and enabling high‑fidelity, bacteria‑free DNA production.